Tralokinumab
Tralokinumab is a monoclonal antibody designed for the treatment of asthma and atopic dermatitis. It works by targeting interleukin 13, a cytokine involved in inflammatory responses.
Mechanism of Action[edit]
Tralokinumab is a human IgG4 monoclonal antibody that specifically binds to interleukin 13 (IL-13) and inhibits its interaction with the IL-13 receptor. IL-13 is a central mediator in the pathogenesis of allergic inflammation, such as asthma and atopic dermatitis. By blocking IL-13, tralokinumab reduces inflammatory response, which can lead to an improvement in symptoms.
Clinical Trials[edit]
Tralokinumab has been studied in several clinical trials for its effectiveness in treating asthma and atopic dermatitis. In a Phase IIb study, tralokinumab showed a significant reduction in the annual asthma exacerbation rate compared to placebo. In a Phase III study for atopic dermatitis, tralokinumab showed significant improvements in the Eczema Area and Severity Index (EASI) score and the Dermatology Life Quality Index (DLQI) score compared to placebo.
Side Effects[edit]
Common side effects of tralokinumab include headache, nasopharyngitis, and upper respiratory tract infection. Serious side effects can include hypersensitivity reactions, including anaphylaxis.
Approval[edit]
Tralokinumab was approved for use in the European Union in April 2021 for the treatment of moderate to severe atopic dermatitis in adults who are candidates for systemic therapy.
See Also[edit]
| Interleukin receptor modulators | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
 | This medical article is a stub. You can help WikiMD by expanding the page. |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
